Verastem Inc. has announced leadership changes as part of its strategic transition plan. Michael Kauffman, M.D., Ph.D., has been appointed president of development and will join the executive leadership team. John Johnson, a board member since 2020, has been named chairman of the board, succeeding Dr. Kauffman. Matthew Ros, chief operating officer, will depart as the company streamlines its operational structure.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verastem Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251215015726) on December 15, 2025, and is solely responsible for the information contained therein.
Comments